Biotoxtech Co. Ltd. | |
Stock Exchange | Korea Exchange |
EPS |
KRW259 |
Market Cap |
KRW191.52 B |
Shares Outstanding |
14.56 M |
Public Float |
10.62 M |
Address |
Ochang Science Industrial Complex Cheongju-si NC 28115 Korea, Republic Of |
Employees | - |
Website | http://www.biotoxtech.com |
Updated | 09/14/2018 |
Biotoxtech Co., Ltd. engages in the provision of non-clinical drugs trials. It operates through the following business divisions: Safety Evaluation Research Field, Efficacy Evaluation and Analysis Research Field. The Safety Evaluation Research Field offers studies such as general toxicity, local toxicity, reproductive and developmental, genotoxicity, immunotoxicity, carcinogenicity, safety pharmacology, ecotoxicology, histopathology or hematology. |